Peptide Based Metabolic Disorders Therapeutics Market Report

China Peptide Based Metabolic Disorders Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Aug 18, 2023
  • PAGES：207
  • REPORT CODE：GMM1742275
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Peptide Based Metabolic Disorders Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ipsen

    • Merck

    • Eli Lilly

    • Teva Pharmaceutical

    • Novo Nordisk

    • Ingro Finanz (Bachem)

    • AstraZeneca

    By Type:

    • Liraglutide

    • Exenatide

    • Others

    By Application:

    • Retail Pharmacies

    • Online Pharmacies

    • Hospital Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Peptide Based Metabolic Disorders Therapeutics Market Overview 2018-2029

    • 1.1 China Peptide Based Metabolic Disorders Therapeutics Industry Development Overview

    • 1.2 China Peptide Based Metabolic Disorders Therapeutics Industry Development History

    • 1.3 China Peptide Based Metabolic Disorders Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Peptide Based Metabolic Disorders Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Peptide Based Metabolic Disorders Therapeutics Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)

      • 1.4.2 China Peptide Based Metabolic Disorders Therapeutics Production Volume, Production Value and Growth Rate of Exenatide (2018-2029)

      • 1.4.3 China Peptide Based Metabolic Disorders Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Peptide Based Metabolic Disorders Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Peptide Based Metabolic Disorders Therapeutics Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.2 China Peptide Based Metabolic Disorders Therapeutics Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

      • 1.5.3 China Peptide Based Metabolic Disorders Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • 1.6 China Peptide Based Metabolic Disorders Therapeutics Market Analysis by Region

      • 1.6.1 North China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Peptide Based Metabolic Disorders Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Peptide Based Metabolic Disorders Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Peptide Based Metabolic Disorders Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Peptide Based Metabolic Disorders Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Peptide Based Metabolic Disorders Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Peptide Based Metabolic Disorders Therapeutics Industry Development

    Chapter 3 Peptide Based Metabolic Disorders TherapeuticsIndustry Chain Analysis

    • 3.1 Peptide Based Metabolic Disorders Therapeutics Industry Chain

    • 3.2 Peptide Based Metabolic Disorders Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Peptide Based Metabolic Disorders Therapeutics Market

    • 3.3 Peptide Based Metabolic Disorders Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Peptide Based Metabolic Disorders Therapeutics Market

    Chapter 4 China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 4.1 China Peptide Based Metabolic Disorders Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Peptide Based Metabolic Disorders Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Peptide Based Metabolic Disorders Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Peptide Based Metabolic Disorders Therapeutics Production Volume and Growth Rate of Liraglutide

      • 4.5.2 China Peptide Based Metabolic Disorders Therapeutics Production Volume and Growth Rate of Exenatide

      • 4.5.3 China Peptide Based Metabolic Disorders Therapeutics Production Volume and Growth Rate of Others

    Chapter 5 China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Peptide Based Metabolic Disorders Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate of Retail Pharmacies

      • 5.5.2 China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate of Online Pharmacies

      • 5.5.3 China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate of Hospital Pharmacies

    Chapter 6 China Peptide Based Metabolic Disorders Therapeutics Market, by Region

    • 6.1 China Peptide Based Metabolic Disorders Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Peptide Based Metabolic Disorders Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Peptide Based Metabolic Disorders Therapeutics Market Analysis

    • 7.1 North China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 7.2 North China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    Chapter 8 Central China Peptide Based Metabolic Disorders Therapeutics Market Analysis

    • 8.1 Central China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 8.2 Central China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    Chapter 9 South China Peptide Based Metabolic Disorders Therapeutics Market Analysis

    • 9.1 South China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 9.2 South China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    Chapter 10 East China Peptide Based Metabolic Disorders Therapeutics Market Analysis

    • 10.1 East China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 10.2 East China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    Chapter 11 Northeast China Peptide Based Metabolic Disorders Therapeutics Market Analysis

    • 11.1 Northeast China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 11.2 Northeast China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    Chapter 12 Southwest China Peptide Based Metabolic Disorders Therapeutics Market Analysis

    • 12.1 Southwest China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 12.2 Southwest China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    Chapter 13 Northwest China Peptide Based Metabolic Disorders Therapeutics Market Analysis

    • 13.1 Northwest China Peptide Based Metabolic Disorders Therapeutics Market, by Type

    • 13.2 Northwest China Peptide Based Metabolic Disorders Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ipsen

        • 14.1.1 Ipsen Company Profile

        • 14.1.2 Ipsen Peptide Based Metabolic Disorders Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Merck

        • 14.2.1 Merck Company Profile

        • 14.2.2 Merck Peptide Based Metabolic Disorders Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eli Lilly

        • 14.3.1 Eli Lilly Company Profile

        • 14.3.2 Eli Lilly Peptide Based Metabolic Disorders Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Teva Pharmaceutical

        • 14.4.1 Teva Pharmaceutical Company Profile

        • 14.4.2 Teva Pharmaceutical Peptide Based Metabolic Disorders Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novo Nordisk

        • 14.5.1 Novo Nordisk Company Profile

        • 14.5.2 Novo Nordisk Peptide Based Metabolic Disorders Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ingro Finanz (Bachem)

        • 14.6.1 Ingro Finanz (Bachem) Company Profile

        • 14.6.2 Ingro Finanz (Bachem) Peptide Based Metabolic Disorders Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AstraZeneca

        • 14.7.1 AstraZeneca Company Profile

        • 14.7.2 AstraZeneca Peptide Based Metabolic Disorders Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Peptide Based Metabolic Disorders Therapeutics Industry Research Conclusions

    • 15.2 Peptide Based Metabolic Disorders Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Peptide Based Metabolic Disorders Therapeutics Industry Market Size (2018-2029)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Volume, Production Value and Growth Rate of Exenatide (2018-2029)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure North China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Peptide Based Metabolic Disorders Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Peptide Based Metabolic Disorders Therapeutics Market Share by Type in 2018

    • Figure China Peptide Based Metabolic Disorders Therapeutics Market Share by Type in 2023

    • Figure China Peptide Based Metabolic Disorders Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Volume and Growth Rate of Liraglutide (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Volume and Growth Rate of Exenatide (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Market Share by Application in 2018

    • Figure China Peptide Based Metabolic Disorders Therapeutics Market Share by Application in 2023

    • Figure China Peptide Based Metabolic Disorders Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Production Volume by Region (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Production Value by Region (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Production Value Share by Region (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Region (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Sales Value by Region (2018-2023)

    • Table China Peptide Based Metabolic Disorders Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Peptide Based Metabolic Disorders Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Peptide Based Metabolic Disorders Therapeutics Production Volume by Type (2018-2023)

    • Table North China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Peptide Based Metabolic Disorders Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Peptide Based Metabolic Disorders Therapeutics Production Volume by Type (2018-2023)

    • Table South China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Peptide Based Metabolic Disorders Therapeutics Production Volume by Type (2018-2023)

    • Table East China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Peptide Based Metabolic Disorders Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Peptide Based Metabolic Disorders Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Peptide Based Metabolic Disorders Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Peptide Based Metabolic Disorders Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Peptide Based Metabolic Disorders Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Peptide Based Metabolic Disorders Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Ipsen Company Profile

    • Table Ipsen Peptide Based Metabolic Disorders Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Peptide Based Metabolic Disorders Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Peptide Based Metabolic Disorders Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Peptide Based Metabolic Disorders Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Peptide Based Metabolic Disorders Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Ingro Finanz (Bachem) Company Profile

    • Table Ingro Finanz (Bachem) Peptide Based Metabolic Disorders Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Peptide Based Metabolic Disorders Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US